Institutional Enthusiasm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Institutional Enthusiasm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Institutional Enthusiasm Today - Breaking & Trending Today

OS Therapies Announces Dosing of First Patient in a Phase IIb Trial of OST-HER2 (Listeria monocytogenes) in Recurred, Resected Osteosarcoma

Published: October 22, 2021

/PRNewswire/ -- OS Therapies, a research and clinical-stage biopharmaceutical company announced today the dosing of the "First Patient In" for its lead...

Source: prnewswire.com

Related Topics:

United KingdomUnited StatesNew ZealandDouglass HawkinsRobert PetitDamon ReedNational Clinical Trials NetworkUniversity Of WashingtonChildren Oncology GroupOsteosarcoma CommunityMoffitt Cancer CenterOs Therapies IncOrphan DesignationOverall SurvivalDisease ProgressionOncology GroupSeattle ChildrenInstitutional EnthusiasmPrinciple InvestigatorMoffitt CancerClinical Trials NetworkNorth AmericaOrphan DesignationsRare Disease DesignationBreak Through Designation